全静脉麻醉改善重度慢性鼻窦炎手术术中视野:双盲随机对照试验
这项双盲随机对照试验纳入72例重度慢性鼻窦炎(鼻息肉或Lund-Mackay评分≥12)行内镜鼻窦手术的成人,比较全静脉麻醉(TIVA)与吸入麻醉(IA)。TIVA组术中Wormald视野评分中位数3.5优于IA组4.1(p=0.0089),出血量200 mL少于300 mL(p=0.046),但术后3个月和6个月SNOT-22生活质量评分无显著差异。
要点
- TIVA可改善重度炎性鼻窦疾病ESS术中视野清晰度并减少出血。
- 该研究未发现TIVA对术后3个月和6个月SNOT-22生活质量有显著影响。
- 两组基线特征可比,术后无显著并发症。
核心结论
- 对于重度炎性鼻窦疾病行ESS的患者,TIVA有助于改善术中视野并减少出血量。
研究设计与样本
- 双盲随机对照试验,在三级医疗中心纳入72例成人,TIVA组37例、IA组35例。
- 纳入标准为重度慢性鼻窦炎,定义为鼻息肉或术前Lund-Mackay评分≥12。
主要发现
- 所有评审者的Wormald评分汇总中位数(四分位距)TIVA组为3.5(2.4-3.9),IA组为4.1(3.0-5.8),p=0.0089。
- TIVA组出血量中位数200 mL(100-450),IA组300 mL(200-500),p=0.046。
- 术后3个月SNOT-22评分组间比较p=0.278,6个月p=0.396,均无显著差异。
- 两组基线特征可比,术后无显著并发症。
关键数值与推荐
- 主要结局为3名盲法评审者使用10分Wormald手术野分级量表评定的术中可见度。
- 次要结局包括手术出血量、并发症及SNOT-22评估的生活质量变化。
临床怎么用
- 对重度炎性鼻窦疾病行ESS时,可考虑选用TIVA以改善术中视野并减少出血。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total intravenous anesthesia (TIVA) has been proposed as a method to reduce blood loss during endoscopic sinus surgery (ESS). Impaired sinonasal visualization due to mucosal bleeding may be burdensome in cases of chronic rhinosinusitis (CRS) with high-grade inflammatory disease, suggesting a role for TIVA in that disease subgroup. METHODS: A double-blind, randomized controlled trial was conducted of adults undergoing ESS at a tertiary medical center. Patients considered for inclusion had high-grade CRS defined as either sinonasal polyposis or a preoperative Lund-Mackay score of ≥12. Subjects were randomized to receive either TIVA or inhaled anesthesia (IA) during ESS. The primary outcome measure was intraoperative visibility as rated by 3 blinded reviewers utilizing the 10-point Wormald Surgical Field Grading Scale. Secondary outcomes included operative blood loss, complications, and change in quality of life evaluated by the 22-item Sino-Nasal Outcome Test (SNOT-22). RESULTS: A total of 72 patients were randomized into TIVA (n = 37) and IA (n = 35) study arms. Aggregate median (interquartile range) Wormald scores across all reviewers demonstrated a more favorable visual field with TIVA compared to IA (3.5 [2.4-3.9] vs IA 4.1[3.0-5.8], p = 0.0089). There was significantly less blood loss in the TIVA group compared to the IA group (200 mL [100-450] vs 300 mL [200-500], p = 0.046). Baseline patient characteristics were comparable between cohorts with no significant postoperative complications. No significant changes were detected between postoperative SNOT-22 scores at 3 months (p = 0.278) and at 6 months (p = 0.396) following ESS. CONCLUSION: TIVA contributes to improved intraoperative visualization and decreased blood loss in patients undergoing ESS for high-grade inflammatory sinus disease.
引用
- Brunner JP, Levy JM, Ada ML, et al. Total intravenous anesthesia improves intraoperative visualization during surgery for high-grade chronic rhinosinusitis: a double-blind randomized controlled trial. Int Forum Allergy Rhinol. 2018. PMID: 29979837. doi:10.1002/alr.22173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。